• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动物研究在预测临床试验中毒性方面的局限性:是时候重新思考我们当前的方法了吗?

Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?

作者信息

Van Norman Gail A

机构信息

Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington.

出版信息

JACC Basic Transl Sci. 2019 Nov 25;4(7):845-854. doi: 10.1016/j.jacbts.2019.10.008. eCollection 2019 Nov.

DOI:10.1016/j.jacbts.2019.10.008
PMID:31998852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6978558/
Abstract

Animal testing is used in pharmaceutical and industrial research to predict human toxicity, and yet analysis suggests that animal models are poor predictors of drug safety in humans. The cost of animal research is high-in dollars, delays in drug approval, and in the loss of potentially beneficial drugs for human use. Human subjects have been harmed in the clinical testing of drugs that were deemed safe by animal studies. Increasingly, investigators are questioning the scientific merit of animal research. This review discusses issues in using animals to predict human toxicity in pharmaceutical development. Part 1 focuses on scientific concerns over the validity of animal research. Part 2 will discuss alternatives to animal research and their validation and use in production of human pharmaceuticals.

摘要

动物实验被用于制药和工业研究以预测人类毒性,但分析表明动物模型在预测药物对人类的安全性方面表现不佳。动物研究的成本很高,包括金钱成本、药物审批延迟以及失去潜在有益的人类用药。在动物研究中被认为安全的药物的临床试验中,人类受试者受到了伤害。越来越多的研究人员开始质疑动物研究的科学价值。本综述讨论了在药物研发中使用动物预测人类毒性的相关问题。第1部分重点关注对动物研究有效性的科学担忧。第2部分将讨论动物研究的替代方法及其在人类药物生产中的验证和应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/b3bbc22aa5f5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/2bc0ae60bccd/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/eb883f7f3f91/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/5359b3b86d63/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/b3bbc22aa5f5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/2bc0ae60bccd/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/eb883f7f3f91/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/5359b3b86d63/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5428/6978558/b3bbc22aa5f5/gr3.jpg

相似文献

1
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?动物研究在预测临床试验中毒性方面的局限性:是时候重新思考我们当前的方法了吗?
JACC Basic Transl Sci. 2019 Nov 25;4(7):845-854. doi: 10.1016/j.jacbts.2019.10.008. eCollection 2019 Nov.
2
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Part 2: Potential Alternatives to the Use of Animals in Preclinical Trials.动物研究在预测临床试验中毒性方面的局限性:第2部分:临床前试验中使用动物的潜在替代方法。
JACC Basic Transl Sci. 2020 Apr;5(4):387-397. doi: 10.1016/j.jacbts.2020.03.010. Epub 2020 Apr 27.
3
Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: The IQ consortium nonclinical to clinical translational database.当前的非临床测试模式助力安全开展首次人体临床试验:IQ联盟非临床到临床转化数据库
Toxicol Appl Pharmacol. 2017 Nov 1;334:100-109. doi: 10.1016/j.taap.2017.09.006. Epub 2017 Sep 8.
4
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.转基因植物及其衍生食品和饲料的安全性与营养评估:动物饲养试验的作用
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations.制药行业、支持动物测试游说团体和动物福利组织最近努力阐明动物药物测试的科学有效性。
BMC Med Ethics. 2019 Mar 1;20(1):16. doi: 10.1186/s12910-019-0352-3.
7
Limited added value of T-SPOT.TB blood test in diagnosing active TB: a prospective bayesian analysis.T-SPOT.TB 血液检测在诊断活动性结核病方面的附加价值有限:一项前瞻性贝叶斯分析。
J Infect. 2011 Jun;62(6):456-61. doi: 10.1016/j.jinf.2011.04.003. Epub 2011 Apr 15.
8
AMCP Partnership Forum: Enabling the Exchange of Clinical and Economic Information Pre-FDA Approval.AMCP 合作论坛:在 FDA 批准前实现临床和经济信息的交流。
J Manag Care Spec Pharm. 2017 Jan;23(1):105-112. doi: 10.18553/jmcp.2016.16366. Epub 2016 Dec 22.
9
The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为胃肠道恶性肿瘤标志物的准确性。
J Gastrointest Oncol. 2018 Oct;9(5):972-978. doi: 10.21037/jgo.2018.08.05.
10
Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs.药物、器械与美国食品药品监督管理局:第一部分:药物审批流程概述
JACC Basic Transl Sci. 2016 Apr 25;1(3):170-179. doi: 10.1016/j.jacbts.2016.03.002. eCollection 2016 Apr.

引用本文的文献

1
AdipoRon as a Novel Therapeutic Agent for Depression: A Comprehensive Review of Preclinical Evidence.脂联素受体激动剂AdipoRon作为抑郁症的新型治疗药物:临床前证据的综合综述
Biomedicines. 2025 Jul 31;13(8):1867. doi: 10.3390/biomedicines13081867.
2
Simulating tumor complexity: 3D pancreatic tumor spheroid model for improved drug screening.模拟肿瘤复杂性:用于改进药物筛选的3D胰腺肿瘤球体模型
Hum Cell. 2025 Aug 23;38(5):149. doi: 10.1007/s13577-025-01277-w.
3
Pharmacotherapeutic potential of daidzein: insights into mechanisms and clinical relevance.

本文引用的文献

1
US lawmakers propose plan to reduce primate research at National Institutes of Health.美国立法者提议削减美国国立卫生研究院灵长类动物研究的计划。
Nature. 2019 May 9. doi: 10.1038/d41586-019-01511-0.
2
Beyond the 3Rs: Expanding the use of human-relevant replacement methods in biomedical research.超越 3Rs:在生物医药研究中扩展使用与人类相关的替代方法。
ALTEX. 2019;36(3):343-352. doi: 10.14573/altex.1907031.
3
Phase II Trials in Drug Development and Adaptive Trial Design.药物研发中的II期试验与适应性试验设计
大豆苷元的药物治疗潜力:对作用机制及临床相关性的见解
Inflammopharmacology. 2025 Aug 20. doi: 10.1007/s10787-025-01891-y.
4
Phytoestrogenic Food Intake and the Early Development of Pubertal Characteristics: A Scoping Review and Evidence Assessment.植物雌激素的食物摄入量与青春期特征的早期发育:一项范围综述和证据评估
Sage Open Pediatr. 2025 Aug 16;12:30502225251361989. doi: 10.1177/30502225251361989. eCollection 2025 Jan-Dec.
5
Neural organoids as advanced tools for neurotoxicity modeling.神经类器官作为神经毒性建模的先进工具。
Curr Res Toxicol. 2025 Jul 11;9:100249. doi: 10.1016/j.crtox.2025.100249. eCollection 2025.
6
Bioprinting for drug screening: A path toward reducing animal testing or redefining preclinical research?用于药物筛选的生物打印:是减少动物实验的途径还是重新定义临床前研究?
Bioact Mater. 2025 Jul 15;51:993-1017. doi: 10.1016/j.bioactmat.2025.07.006. eCollection 2025 Sep.
7
Therapeutic mechanisms of polysaccharides in the management of rheumatoid arthritis: a comprehensive review.多糖在类风湿关节炎治疗中的作用机制:综述
Front Immunol. 2025 Jul 1;16:1608909. doi: 10.3389/fimmu.2025.1608909. eCollection 2025.
8
Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro.动态刺激促进体外三维人淋巴微环境模型的功能性组织样结构形成。
Cell Rep Methods. 2025 Jul 21;5(7):101105. doi: 10.1016/j.crmeth.2025.101105. Epub 2025 Jul 11.
9
Engineering the bone metastatic prostate cancer niche through a microphysiological system to report patient-specific treatment response.通过微生理系统构建骨转移性前列腺癌微环境以报告患者特异性治疗反应。
Commun Biol. 2025 Jul 1;8(1):961. doi: 10.1038/s42003-025-08384-2.
10
Bioprinted Four-Cell-Type Lung Model for Viral Infection Studies Under Air-Liquid Interface Conditions.用于气液界面条件下病毒感染研究的生物打印四细胞类型肺模型
Int J Mol Sci. 2025 Jun 10;26(12):5543. doi: 10.3390/ijms26125543.
JACC Basic Transl Sci. 2019 Jun 24;4(3):428-437. doi: 10.1016/j.jacbts.2019.02.005. eCollection 2019 Jun.
4
Translatability of the S7A core battery respiratory safety pharmacology studies: Preclinical respiratory and related clinical adverse events.S7A核心电池呼吸安全药理学研究的可翻译性:临床前呼吸及相关临床不良事件
J Pharmacol Toxicol Methods. 2019 Sep-Oct;99:106596. doi: 10.1016/j.vascn.2019.106596. Epub 2019 Jun 5.
5
The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment.西海岸地区安全药理学学会会议最新情况:填补安全性评估中的转化差距。
J Pharmacol Toxicol Methods. 2019 Jul-Aug;98:106582. doi: 10.1016/j.vascn.2019.106582. Epub 2019 May 9.
6
Exploring new technologies in biomedical research.探索生物医学研究中的新技术。
Drug Discov Today. 2019 Jun;24(6):1242-1247. doi: 10.1016/j.drudis.2019.04.001. Epub 2019 Apr 4.
7
Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development.0期,包括微剂量给药方法:应用“3R”原则并提高人类药物研发效率。
Altern Lab Anim. 2018 Dec;46(6):335-346. doi: 10.1177/026119291804600603.
8
Organ-on-chip models: Implications in drug discovery and clinical applications.器官芯片模型:在药物发现和临床应用中的意义。
J Cell Physiol. 2019 Jun;234(6):8352-8380. doi: 10.1002/jcp.27729. Epub 2018 Nov 15.
9
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail.临床前动物研究中的外部有效性问题能否克服?为什么大多数动物模型注定会失败。
J Transl Med. 2018 Nov 7;16(1):304. doi: 10.1186/s12967-018-1678-1.
10
Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs.药物、器械与美国食品药品监督管理局:第一部分:药物审批流程概述
JACC Basic Transl Sci. 2016 Apr 25;1(3):170-179. doi: 10.1016/j.jacbts.2016.03.002. eCollection 2016 Apr.